ScholarIQanswers from OpenAlex

Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective

PaperCitations, authors & open-access status

Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective have?

ScholarIQcitation count

Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective has 178 citations in the OpenAlex counts ScholarIQ stores.

When was Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective published?

ScholarIQyear

Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective has 2020 year in the ScholarIQ index.

What is the open-access status of Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective?

ScholarIQoa status

Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective has hybrid oa status in the ScholarIQ index.

What is the DOI of Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective?

ScholarIQdoi

The DOI for Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective is on the source record.

What is the PMID of Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective?

ScholarIQpmid

The PMID for Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective is on the source record.

What is the OpenAlex record for Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective?

ScholarIQopenalex

The OpenAlex for Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial